DHCR7 and lymphoma: In lymphoma, 7-Dehydrocholesterol, an endogenous metabolite, enhances the survival ability of lymphoma cells by protecting their lipids from peroxidation and reducing their sensitivity to ferroptosis, especially for DHCR7-mutated Burkitt lymphoma (Freitas et al., 2024).